ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 133,92
0,06%
DAX
18 155,24
-0,04%
Brent Oil
84,185
0,00%
Bitcoin
61 415,92
-0,64%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Therapeutics Acquisition Corp (RACA)

  7. Therapeutics Acquisition Corp (RACA) Actualités

RACA

Therapeutics Acquisition (RACA)

Therapeutics Acquisition Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RACA
DateHeureSourceTitreSymboleSociété
15/06/202300h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
15/06/202300h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RACATherapeutics Acquisition Corp
05/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
01/05/202319h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:RACATherapeutics Acquisition Corp
27/04/202314h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RACATherapeutics Acquisition Corp
27/03/202313h55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RACATherapeutics Acquisition Corp
14/02/202318h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RACATherapeutics Acquisition Corp
03/02/202318h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RACATherapeutics Acquisition Corp
22/11/202222h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RACATherapeutics Acquisition Corp
14/11/202213h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RACATherapeutics Acquisition Corp
14/09/202222h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RACATherapeutics Acquisition Corp
12/08/202214h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RACATherapeutics Acquisition Corp
12/07/202212h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RACATherapeutics Acquisition Corp
01/07/202222h14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RACATherapeutics Acquisition Corp
16/05/202214h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
18/03/202200h20Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:RACATherapeutics Acquisition Corp
15/02/202200h53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:RACATherapeutics Acquisition Corp
08/02/202220h25Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:RACATherapeutics Acquisition Corp
30/07/202122h52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RACATherapeutics Acquisition Corp
12/07/202122h38Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:RACATherapeutics Acquisition Corp
08/07/202117h39Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:RACATherapeutics Acquisition Corp
30/06/202122h05GlobeNewswire Inc.POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics CompanyNASDAQ:RACATherapeutics Acquisition Corp
21/06/202122h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RACATherapeutics Acquisition Corp
09/06/202122h30Business WireResearch Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINTNASDAQ:RACATherapeutics Acquisition Corp
07/06/202112h01Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:RACATherapeutics Acquisition Corp
04/06/202114h30Business WirePOINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPCNASDAQ:RACATherapeutics Acquisition Corp
01/06/202122h31Business WirePOINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana FacilityNASDAQ:RACATherapeutics Acquisition Corp
23/03/202111h07Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:RACATherapeutics Acquisition Corp
18/03/202114h09Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:RACATherapeutics Acquisition Corp
08/12/202016h17GlobeNewswire Inc.Cerevance Appoints David Lubner to Board of DirectorsNASDAQ:RACATherapeutics Acquisition Corp
 Showing the most relevant articles for your search:NASDAQ:RACA

Dernières Valeurs Consultées

CSE
PKB
PeakBirch Commerce
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés